SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,693,150 | -28.2% | 13,968 | -32.2% | 0.00% | -25.0% |
| Q2 2023 | $2,357,611 | -30.6% | 20,588 | -16.5% | 0.00% | -33.3% |
| Q1 2023 | $3,398,929 | +214.4% | 24,661 | +196.1% | 0.01% | +200.0% |
| Q4 2022 | $1,081,031 | +133.0% | 8,329 | +97.9% | 0.00% | +100.0% |
| Q3 2022 | $464,000 | +41.0% | 4,209 | -4.4% | 0.00% | 0.0% |
| Q2 2022 | $329,000 | -13.0% | 4,402 | -9.0% | 0.00% | 0.0% |
| Q1 2022 | $378,000 | -20.4% | 4,838 | -8.1% | 0.00% | 0.0% |
| Q4 2021 | $475,000 | -24.4% | 5,263 | -22.6% | 0.00% | 0.0% |
| Q3 2021 | $628,000 | +11.0% | 6,799 | -6.7% | 0.00% | 0.0% |
| Q2 2021 | $566,000 | +13.2% | 7,287 | +8.6% | 0.00% | 0.0% |
| Q1 2021 | $500,000 | -44.7% | 6,709 | +26.5% | 0.00% | -50.0% |
| Q4 2020 | $904,000 | +1.9% | 5,304 | -16.0% | 0.00% | -33.3% |
| Q3 2020 | $887,000 | -3.3% | 6,318 | +10.4% | 0.00% | 0.0% |
| Q2 2020 | $917,000 | +53.9% | 5,724 | -57.4% | 0.00% | +50.0% |
| Q1 2020 | $596,000 | – | 13,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |